BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 20534996)

  • 1. Periodic acid-schiff is superior to hematoxylin and eosin for screening prophylactic gastrectomies from CDH1 mutation carriers.
    Lee AF; Rees H; Owen DA; Huntsman DG
    Am J Surg Pathol; 2010 Jul; 34(7):1007-13. PubMed ID: 20534996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications.
    Rogers WM; Dobo E; Norton JA; Van Dam J; Jeffrey RB; Huntsman DG; Kingham K; Chun N; Ford JM; Longacre TA
    Am J Surg Pathol; 2008 Jun; 32(6):799-809. PubMed ID: 18391748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members.
    Mayrbaeurl B; Keller G; Schauer W; Burgstaller S; Czompo M; Hoebling W; Knoflach P; Duba HC; Hoefler H; Thaler J
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):306-10. PubMed ID: 19474748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening.
    Carneiro F; Huntsman DG; Smyrk TC; Owen DA; Seruca R; Pharoah P; Caldas C; Sobrinho-Simões M
    J Pathol; 2004 Jun; 203(2):681-7. PubMed ID: 15141383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
    Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
    Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
    Cisco RM; Ford JM; Norton JA
    Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDH1 associated gastric cancer: a report of a family and review of the literature.
    Moran CJ; Joyce M; McAnena OJ
    Eur J Surg Oncol; 2005 Apr; 31(3):259-64. PubMed ID: 15780560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
    de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]Fluoro-2-deoxy-D-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic E-cadherin mutation carrier.
    van Kouwen MC; Drenth JP; Oyen WJ; de Bruin JH; Ligtenberg MJ; Bonenkamp JJ; van Krieken JH; Nagengast FM
    Clin Cancer Res; 2004 Oct; 10(19):6456-9. PubMed ID: 15475432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.
    Ghaffari SR; Rafati M; Sabokbar T; Dastan J
    Eur J Surg Oncol; 2010 Jun; 36(6):559-62. PubMed ID: 20471195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic total gastrectomy for familial gastric cancer.
    Lewis FR; Mellinger JD; Hayashi A; Lorelli D; Monaghan KG; Carneiro F; Huntsman DG; Jackson CE; Caldas C
    Surgery; 2001 Oct; 130(4):612-7; discussion 617-9. PubMed ID: 11602891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic total gastrectomy for hereditary diffuse gastric cancer. Review of the literature.
    Mastoraki A; Danias N; Arkadopoulos N; Sakorafas G; Vasiliou P; Smyrniotis V
    Surg Oncol; 2011 Dec; 20(4):e223-6. PubMed ID: 21872467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Familial gastric cancer: diagnosis, treatment and periodic surveillance].
    Kluijt I; Sijmons RH; Hoogerbrugge N; Vasen HF; Cats A
    Ned Tijdschr Geneeskd; 2011; 155():A2731. PubMed ID: 21329544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions.
    Cisco RM; Norton JA
    Future Oncol; 2008 Aug; 4(4):553-9. PubMed ID: 18684065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
    Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
    Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.
    Newman EA; Mulholland MW
    J Am Coll Surg; 2006 Apr; 202(4):612-7. PubMed ID: 16571431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.